Business Description
Bioray Biotech Co Ltd
ISIN : TW0007561B13
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.39 | |||||
Equity-to-Asset | 0.8 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | 5.75 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 3.92 | |||||
Beneish M-Score | -2.38 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.8 | |||||
3-Year EBITDA Growth Rate | -9.7 | |||||
3-Year FCF Growth Rate | 41.4 | |||||
3-Year Book Growth Rate | 2.3 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 81.85 | |||||
9-Day RSI | 63.9 | |||||
14-Day RSI | 54.09 | |||||
6-1 Month Momentum % | -12.06 | |||||
12-1 Month Momentum % | -25.92 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5 | |||||
Quick Ratio | 3.71 | |||||
Cash Ratio | 2.25 | |||||
Days Inventory | 185.42 | |||||
Days Sales Outstanding | 75.8 | |||||
Days Payable | 32.17 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.87 | |||||
3-Year Dividend Growth Rate | -12 | |||||
Forward Dividend Yield % | 0.87 | |||||
5-Year Yield-on-Cost % | 0.92 | |||||
3-Year Average Share Buyback Ratio | -3.1 | |||||
Shareholder Yield % | 1.45 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 40.48 | |||||
Operating Margin % | -10.08 | |||||
Net Margin % | -6.03 | |||||
FCF Margin % | -5.71 | |||||
ROE % | -2.62 | |||||
ROA % | -2.03 | |||||
ROIC % | -3.67 | |||||
ROC (Joel Greenblatt) % | -3.3 | |||||
ROCE % | -2.5 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 3.59 | |||||
PB Ratio | 1.58 | |||||
Price-to-Tangible-Book | 1.59 | |||||
EV-to-EBIT | -51.44 | |||||
EV-to-EBITDA | 54.53 | |||||
EV-to-Revenue | 3.44 | |||||
EV-to-FCF | -51.94 | |||||
Price-to-Net-Current-Asset-Value | 6.45 | |||||
Earnings Yield (Greenblatt) % | -1.94 | |||||
FCF Yield % | -1.6 | |||||
Forward Rate of Return (Yacktman) % | -25.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Bioray Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 191.83 | ||
EPS (TTM) (NT$) | -0.38 | ||
Beta | 0.06 | ||
Volatility % | 19.71 | ||
14-Day RSI | 54.09 | ||
14-Day ATR (NT$) | 1.153423 | ||
20-Day SMA (NT$) | 21.62 | ||
12-1 Month Momentum % | -25.92 | ||
52-Week Range (NT$) | 18.5 - 35.3 | ||
Shares Outstanding (Mil) | 30.09 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bioray Biotech Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Bioray Biotech Co Ltd Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
Bioray Biotech Co Ltd Frequently Asked Questions
What is Bioray Biotech Co Ltd(ROCO:7561)'s stock price today?
When is next earnings date of Bioray Biotech Co Ltd(ROCO:7561)?
Does Bioray Biotech Co Ltd(ROCO:7561) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |